Norwood Investment Partners LP Makes New Investment in Amrize Ltd $AMRZ

Norwood Investment Partners LP purchased a new stake in Amrize Ltd (NYSE:AMRZ) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 78,200 shares of the company’s stock, valued at approximately $3,795,000. Amrize makes up about 3.3% of Norwood Investment Partners LP’s investment portfolio, making the stock its 13th largest holding.

Several other large investors have also modified their holdings of the business. Bank of New York Mellon Corp acquired a new position in shares of Amrize during the 2nd quarter worth approximately $38,803,000. Metis Global Partners LLC purchased a new position in Amrize during the second quarter worth $635,000. Aviva PLC acquired a new position in shares of Amrize in the second quarter worth $29,836,000. Credit Industriel ET Commercial purchased a new stake in shares of Amrize in the second quarter valued at $109,000. Finally, Rathbones Group PLC acquired a new stake in shares of Amrize during the second quarter valued at $257,000.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on AMRZ. Royal Bank Of Canada boosted their target price on shares of Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a research note on Thursday, February 19th. UBS Group lifted their price target on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, January 8th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research note on Monday, February 23rd. Citigroup lifted their target price on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Finally, Vertical Research began coverage on Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Amrize presently has an average rating of “Moderate Buy” and an average price target of $63.43.

Amrize Price Performance

AMRZ opened at $62.75 on Thursday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94. The company’s 50 day simple moving average is $57.47 and its 200 day simple moving average is $53.31. The stock has a market capitalization of $34.71 billion and a PE ratio of 25.51. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analysts’ expectations of $2.95 billion. The firm’s quarterly revenue was down .4% compared to the same quarter last year.

Insider Buying and Selling at Amrize

In other news, CFO Ian A. Johnston bought 1,200 shares of Amrize stock in a transaction that occurred on Thursday, February 19th. The shares were purchased at an average price of $63.92 per share, for a total transaction of $76,704.00. Following the completion of the acquisition, the chief financial officer owned 18,544 shares of the company’s stock, valued at $1,185,332.48. The trade was a 6.92% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.